Glucose stimulates phagocytosis of unopsonized Pseudomonas aeruginosa by cultivated human alveolar macrophages

Infection and Immunity

Volumn 67, Issue 1, 1999, Pages 16-21

  Wong, Simon Y C ^a,c   Guerdoud, Lila M ^a   Cantin, André ^b   Speert, David P ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF SHERBROOKE   (Canada)

^c EDWARD JENNER INST FOR VACC RES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ANIMAL CELL; ARTICLE; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; LUNG ALVEOLUS MACROPHAGE; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; OPSONIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

PSEUDOMONAS AERUGINOSA;

EID: 0032892730     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.1.16-21.1999     Document Type: Article

References (26)

1. Barghouthi, S., K. D. E. Everett, and D. P. Speert. 1995. Nonopsunic phagocytosis of Pseudomonas aeruginosa requires facilitated transport of D-glucose by macrophages. J. Immunol. 154:3420-3428.
2. cγ and complement receptor expression by alveolar macrophages determines relative importance of IgG and complement in promoting phagocytosis of Pseudomonas aeruginosa. Pediatr. Res. 35:68-77.
3. Botzenhart, K., and G. Doring. 1993. Ecology and epidemiology of Pseudomonas aeruginosa, p. 1-13. In M. Campa, M. Bendinelli, and H. Friedman (ed.), Pseudomonas aeruginosa as an opportunistic pathogen. Plenum Press, New York, N.Y.
4. Cantin, A., C. Allard, and R. Begin. 1989. Increased alveolar plasminogen activator in early asbestosis. Am. Rev. Respir. Dis. 139:604-609.
5. Ettensohn, D. B., M. J. Jankowski, P. G. Duncan, and P. A. Lalor. 1988. Bronchoalveolar lavage in the normal volunteer subject. I. Technical aspects and intrasubject variability. Chest 94:275-280.
6. Everett, K. D. E., S. Barghouthi, and D. P. Speert. 1996. In vitro culture of murine peritoneal and alveolar macrophages modulates phagocytosis of Pseudomonas aeruginosa and glucose transport. J. Leukoc. Biol. 59:539-544.
7. Galloway, D. R. 1993. Role of exotoxins in the pathogenesis of P. aeruginosa infections, p. 107-127. In M. Campa, M. Bendinelli, and H. Friedman (ed.), Pseudomonas aeruginosa as an opportunistic pathogen. Plenum Press, New York, N.Y.
8. Goldstein, E., W. Lippert, and D. Warshauer. 1974. Pulmonary alveolar macrophages: defender against bacterial infection of the lung. J. Clin. Investig. 54:519-528.
9. Gudewicz, P. W. 1981. The effects of cortisone therapy on lung macrophage host defence function and glucose metabolism. Circ. Shock 8:95-103.
10. Kemmerich, B., T. H. Rossing, and J. E. Pennington. 1987. Comparative oxidative microbicidal activity of human blood monocytes and alveolar macrophages and activation by recombinant gamma interferon. Am. Rev. Respir. Dis. 136:266-269.
11. Levine, S. J., P. Larivee, C. Logun, C. W. Angus, F. P. Ognibene, and J. H. Shelhamer. 1995. Tumor necrosis factor-α induces mucin hypersecretion and MUC-2 gene expression by human airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 12:196-204.
12. Low, R. B., and C. A. Bulman. 1977. Substrate transport by the pulmonary alveolar macrophage. Effects of smoke components. Am. Rev. Respir. Dis. 116:423-431.
13. Low, R. B., G. S. Davis, and M. S. Giancola. 1978. Biochemical analyses of bronchoalveolar lavage fluids of healthy human volunteer smokers and non-smokers. Am. Rev. Respir. Dis. 118:863-875.
14. Martin, T. R., C. E. Rubens, and C. B. Wilson. 1988. Lung antibacterial defense mechanisms in infant and adult rats: implications for the pathogenesis of group B streptococcal infections in the neonatal lung. J. Infect. Dis. 157:91-100.
15. Mork, T., and R. E. W. Hancock. 1993. Mechanisms of nonopsonic phagocytosis of Pseudomonas aeruginosa. Infect. Immun. 61:3287-3293.
16. Newsholme, P., R. Curi, S. Gordon, and E. A. Newsholme. 1986. Metabolism of glucose, glutamine, long-chain fatty acids and ketone bodies by murine macrophages. Biochem. J. 239:121-125.
17. Pier, G. B., M. Grout, T. S. Zaidi, J. C. Olsen, L. G. Johnson, J. R. Yankaskas, and J. B. Goldberg. 1996. Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections. Science 271:64-67.
18. Regnis, J. A., M. Robinson, D. L. Bailey, P. Cook, P. Hooper, H.-K. Chan, L. Gonda, G. Bautovich, and P. T. P. Bye. 1994. Mucociliary clearance in patients with cystic fibrosis and in normal subjects. Am. J. Respir. Crit. Care Med. 150:66-71.
19. Rommens, J. M., M. C. Iannuzzi, B. Kerem, M. L. Drumm, B. Melmer, M. Dean, K. Rozmahel, J. L. Cole, D. Kennedy, N. Hidaka, M. Zsiga, M. Buchwald, J. R. Riordan, L. C. Tsui, and F. S. Collins. 1989. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 245: 1059-1065.
20. Saiman, L., and A. Prince. 1993. Pseudomonas aeruginosa pili bind to asia-loGM1 which is increased on the surface of cystic fibrosis epithelial cells. J. Clin. Investig. 92:1875-1880.
21. 2. J. Clin. Investig. 59:443-148.
22. Smith, J. J., S. M. Travis, E. P. Greenberg, and M. J. Welsh. 1996. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 85:229-236.
23. Speert, D. P. 1994. Pseudomonas aeruginosa infections in patients with cystic fibrosis, p. 183-236. In A. L. Baltch and R. P. Smith (ed.), Pseudomonas aeruginosa infections and treatment. Marcel Dekker, Inc., New York, N.Y.
24. Speert, D. P., and S. Gordon. 1992. Phagocytosis of unopsonized Pseudomonas aeruginosa by murine macrophages is a two-step process requiring glucose. J. Clin. Investig. 90:1085-11192.
25. Spiteri, M. A., S. W. Clarke, and L. W. Poulter. 1992. Isolation of phenotypically and functionally distinct macrophage subpopulations from human bronchoalveolar lavage. Eur. Respir. J. 5:717-726.
26. +, and albumin concentrations in alveolar milieu of normal humans and pulmonary sarcoidosis patients. Am. Rev. Respir. Dis. 143:1096-1101.